Investigating Extracellular Vesicles in Viscous Formulations: Interplay of Nanoparticle Tracking and Nanorheology via Interferometric Light Microscopy
Alexandre L., Dubrova A., Kunduru A., Surply E., Ribes C., Boucenna I.
Laboratory Study, published in Small Sci (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- Small Sci (2025)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 40212651
- PMCID
- PMC11935215
- DOI
- 10.1002/smsc.202400319
- Citations
- 3
Abstract (original English)
While extracellular vesicles (EVs) demonstrate growing potential as innovative cell-derived nanobiotherapies in diverse medical contexts, their physical properties (size, integrity, transport, etc.) in drug product formulation remain a critical concern poorly addressed so far. Herein, a methodology that relies on nanoparticle tracking analysis by interferometric light microscopy (ILM) for analyzing the concentration and size distribution of nanoparticles as well as their interactions with their local environment through a nanorheological approach is introduced. The analysis of interference patterns enables nanoparticles tracking not only in aqueous solutions but also in complex media with high-viscosity or non-Newtonian behavior, particularly pertinent for characterizing EV formulations. A proof of concept for in situ tracking of EVs suspended in Poloxamer-407 as drug delivery system is presented. The ILM-based analysis enables to 1) measure the viscosity at the nanoscale for Newtonian and non-Newtonian fluids via calibration beads; 2) analyze data to determine the size distribution of EVs in non-Newtonian complex fluid such as poloxamer formulation, and 3) analyze the interactions of EVs with poloxamer-407. The proposed approach represents a valuable tool to understand the nanorheological behavior of EVs in viscoelastic media in situ as well as a quality control test for EV fo
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.